A PROSPECTIVE EVALUATION OF OPTIMAL SAMPLING THEORY IN THE DETERMINATION OF THE STEADY-STATE PHARMACOKINETICS OF PIPERACILLIN IN FEBRILE NEUTROPENIC CANCER-PATIENTS

被引：29
作者：
DRUSANO, GL
FORREST, A
PLAISANCE, KI
WADE, JC
机构：
[1] UNIV MARYLAND,SCH MED,CTR CANC,BALTIMORE,MD 21201
[2] UNIV MARYLAND,SCH PHARM,DEPT CLIN PHARM,COLLEGE PK,MD 20742
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 06期
关键词：
D O I：
10.1038/clpt.1989.84
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：635 / 641
页数：7
相关论文
共 7 条
[1]   OPTIMAL SAMPLING TIMES FOR PHARMACOKINETIC EXPERIMENTS [J].
DARGENIO, DZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :739-756
[2]   PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS [J].
DARGENIO, DZ ;
SCHUMITZKY, A .
COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02) :115-134
[3]   MOXALACTAM AND PIPERACILLIN - A STUDY OF INVITRO CHARACTERISTICS AND PHARMACOKINETICS IN CANCER-PATIENTS [J].
DRUSANO, GL ;
DEJONGH, C ;
NEWMAN, K ;
JOSHI, J ;
WHARTON, R ;
MOODY, MR ;
SCHIMPFF, SC .
INFECTION, 1985, 13 (01) :20-26
[4]   AN EVALUATION OF OPTIMAL SAMPLING STRATEGY AND ADAPTIVE STUDY DESIGN [J].
DRUSANO, GL ;
FORREST, A ;
SNYDER, MJ ;
REED, MD ;
BLUMER, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) :232-238
[5]  
Gibaldi M, 1982, PHARMACOKINETICS REV, V2nd, P45
[6]   AN EVALUATION OF POPULATION PHARMACOKINETICS IN THERAPEUTIC TRIALS .1. COMPARISON OF METHODOLOGIES [J].
GRASELA, TH ;
ANTAL, EJ ;
TOWNSEND, RJ ;
SMITH, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :605-612
[7]  
WILSON CB, 1982, ANTIMICROB AGENTS CH, V22, P442, DOI 10.1128/AAC.22.3.442
1